Sacubitril/Valsartan Induces Global Cardiac Reverse Remodeling in Long-Lasting Heart Failure with Reduced Ejection Fraction: Standard and Advanced Echocardiographic Evidences

Sacubitril/valsartan reduces mortality in heart failure with reduced ejection fraction (HFrEF) patients, partially due to cardiac reverse remodeling (RR). Little is known about the RR rate in long-lasting HFrEF and the evolution of advanced echocardiographic parameters, despite their known prognosti...

Full description

Bibliographic Details
Main Authors: Matteo Castrichini, Paolo Manca, Vincenzo Nuzzi, Giulia Barbati, Antonio De Luca, Renata Korcova, Davide Stolfo, Andrea Di Lenarda, Marco Merlo, Gianfranco Sinagra
Format: Article
Language:English
Published: MDPI AG 2020-03-01
Series:Journal of Clinical Medicine
Subjects:
Online Access:https://www.mdpi.com/2077-0383/9/4/906